| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Effect of SMURF2 targeting on susceptibility to MEK inhibitors in melanoma. | J Natl Cancer Inst | 2012 | 2.01 |
| 2 | FGF-2 protects small cell lung cancer cells from apoptosis through a complex involving PKCepsilon, B-Raf and S6K2. | EMBO J | 2006 | 1.61 |
| 3 | Ras subcellular localization defines extracellular signal-regulated kinase 1 and 2 substrate specificity through distinct utilization of scaffold proteins. | Mol Cell Biol | 2008 | 1.50 |
| 4 | Distinct utilization of effectors and biological outcomes resulting from site-specific Ras activation: Ras functions in lipid rafts and Golgi complex are dispensable for proliferation and transformation. | Mol Cell Biol | 2006 | 1.46 |
| 5 | Differences on the inhibitory specificities of H-Ras, K-Ras, and N-Ras (N17) dominant negative mutants are related to their membrane microlocalization. | J Biol Chem | 2002 | 1.31 |
| 6 | Targeting MITF in the tolerance-phase. | Oncotarget | 2016 | 0.75 |